Published in
Springer Nature [academic journals on nature.com], Blood Cancer Journal, 9(7), p. e604-e604, 2017
DOI: 10.1038/bcj.2017.87
Links
- ORCID
- Springer Nature [academic journals on nature.com] | PDF
- [helda.helsinki.fi] | PDF
- [tampub.uta.fi] | PDF
- [europepmc.org] | PDF
Tools
In silico and preclinical drug screening identifies dasatinib as a targeted therapy for T-ALL
Journal article published in 2017 by
S. Laukkanen,
T. Grönroos,
P. Pölönen,
H. Kuusanmäki 
,
J. Mehtonen,
J. Cloos,
G. Ossenkoppele,
B. Gjertsen,
B. Øystein,
C. Heckman,
M. Heinäniemi,
M. Kontro,
O. Lohi
,
J. Mehtonen,
J. Cloos,
G. Ossenkoppele,
B. Gjertsen,
B. Øystein,
C. Heckman,
M. Heinäniemi,
M. Kontro,
O. Lohi
This paper is made freely available by the publisher.
Full text: Download
Postprint:
archiving forbidden
Data provided by 